Stocks · Health care · Pharmaceutical Preparations

IMPACT BIOMEDICAL INC.

IBO Clue Score30
United States Fiscal year ends December CIK 0001834105

What the insiders did Net selling

By person

11 insiders · 42 transactions

There is no salary here to measure against. IMPACT BIOMEDICAL INC.'s chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Heng Fai Ambrose Chan
Director
—
$4.21M (12)
−$4.21M
32,112
$226.67K
−99.3%
Dss, Inc. entity
10% owner
$155.86K (4)
$3.24M (19)
−$3.08M
1,768,400
$12.48M
−50.7%
Jason Grady
Director
—
$32.51K (1)
−$32.51K
28,164
$198.80K
−65.8%
Todd D Macko
Chief Financial Officer
—
$25.33K (2)
−$25.33K
16,462
$116.20K
−74.9%
Frank D Heuszel
Chief Executive Officer
$5.17K (4)
—
+$5.17K
97,344
$687.12K
+2.2%
Mark Suseck
Chief Operating Officer
—
—
—
32,112
$226.67K
−11.5%
Christian Thomas Zimmerman
Director
—
—
—
32,112
$226.67K
−11.5%
Castel Berisford Hibbert
Director
—
—
—
32,112
$226.67K
−11.5%
Melissa Kaye Sims
Director
—
—
—
32,112
$226.67K
−11.5%
David K Keene
Director
—
—
—
32,112
$226.67K
−11.5%
Elise Brownell
Director
—
—
—
32,112
$226.67K
−11.5%

No percentages here. This company's share count has moved by a factor of 8.9 over the window, from 12,085,412 to 107,821,231 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.